An Evaluation of Testosterone Flare During a Transition from Degarelix to Leuprolide in Men on ADT *
Many men with advanced prostate cancer who are on hormone therapy (ADT) use one of the newer drugs, degarelix (Firmagon) to achieve a state of castration. Degarelix is considered a superior drug for initiating ADT [...]
For Caregivers – Common Signs of Impending Cancer Death
Advanced Prostate cancer will eventually lead to our death. This is a sad truth that I know we all are very aware. In a study published Monday online in Cancer, researchers identify “eight specific physical [...]
*Provenge to Survive Dendreon’s Bankruptcy – Welcome Valeant to the Prostate Cancer Community
Dendreon, the manufacture of the only FDA approved immunologic therapy for prostate cancer had been burdened with significant debt. The debt came from their R&D of Provenge, their seeking FDA approval and the construction of [...]
*After the Failure of Docetaxel Is There A Best Sequence For Other Treatments?: Results of an Italian Multicenter Study
As we all know there are now a number of new drugs available to treat castrate resistant metastatic prostate cancer (mCRPC). The availability of these new drugs (abiraterone acetate aka Zytiga, cabazitaxel aka Jevtana, and [...]
Understanding the Complexities of Bone Metastases in Prostate Cancer
Our bones operate in a balanced and dynamic system, which in the normal situation keep them strong. Bones are constantly being eliminated and then remade to keep them healthy and read to support our frame. [...]
Obama Says “Men, You Don’t Count” As He Eliminates All Prostate Cancer Funding From His Proposed 2016 Budget At The CDC
Men, you don’t count! You have NO VALUE! That is the absolute truth according to President Obama. Just released budget documents from the President proposed budget for 2016 recommends that ALL CDC funding for Prostate [...]